209 related articles for article (PubMed ID: 26718651)
1. Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.
Zhu J; Sun C; Wang L; Xu M; Zang Y; Zhou Y; Liu X; Tao W; Xue B; Shan Y; Yang D
Mol Med Rep; 2016 Feb; 13(2):1602-10. PubMed ID: 26718651
[TBL] [Abstract][Full Text] [Related]
2. Polypurine reverse Hoogsteen hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivo.
Rodríguez L; Villalobos X; Dakhel S; Padilla L; Hervas R; Hernández JL; Ciudad CJ; Noé V
Biochem Pharmacol; 2013 Dec; 86(11):1541-54. PubMed ID: 24070653
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
4. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
5. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein.
Shao Y; Liu Y; Shao C; Hu J; Li X; Li F; Zhang L; Zhao D; Sun L; Zhao X; Kopecko DJ; Kalvakolanu DV; Li Y; Xu DQ
Cancer Gene Ther; 2010 Dec; 17(12):844-54. PubMed ID: 20706288
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
Habib R; Akhtar J; Taqi M; Yu C; Zhang C
Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
[TBL] [Abstract][Full Text] [Related]
9. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin.
Xu D; Wang Q; An Y; Xu L
Mol Med Rep; 2013 Aug; 8(2):379-84. PubMed ID: 23732815
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
11. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
13. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
[TBL] [Abstract][Full Text] [Related]
14. Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells.
Yang AQ; Wang PJ; Huang T; Zhou WL; Landman J
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173182
[TBL] [Abstract][Full Text] [Related]
15. The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
Luk SU; Xue H; Cheng H; Lin D; Gout PW; Fazli L; Collins CC; Gleave ME; Wang Y
Oncotarget; 2014 Aug; 5(16):6896-908. PubMed ID: 25071009
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.
Liu YB; Zhang L; Guo YX; Gao LF; Liu XC; Zhao LJ; Guo BF; Zhao LJ; Zhao XJ; Xu DQ
Asian J Androl; 2012 Jul; 14(4):536-45. PubMed ID: 22580637
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
19. Altered miRNA expression in high-fat diet-induced prostate cancer progression.
Nara T; Narita S; Mingguo H; Yoshioka T; Koizumi A; Numakura K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
Carcinogenesis; 2016 Dec; 37(12):1129-1137. PubMed ID: 27915273
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
Xu S; Adisetiyo H; Tamura S; Grande F; Garofalo A; Roy-Burman P; Neamati N
Br J Cancer; 2015 Jul; 113(2):242-51. PubMed ID: 26103574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
